Skip to main content
. 2018 Jun 4;97(10):1825–1839. doi: 10.1007/s00277-018-3380-z

Fig. 2.

Fig. 2

Achievable lenalidomide doses in combination treatment throughout the trial. a Maximum tolerated doses in induction combination with fludarabine and rituximab established by individual per patient dose finding. b Dose administered with the last of six cycles of FR (includes dose reductions after two stable cycles at the established MTD). c Fraction of on-trial patients per individual dose level per cycle of treatment